• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 初免和康复个体接种灭活疫苗后外周血单个核细胞的转录组分析。

Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine.

机构信息

Infectious Disease Prevention and Control Section, Shandong Center for Disease Control and Prevention, Jinan, China.

Infectious Disease Prevention and Control Section, School of Public Health and Health Management, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

出版信息

Front Cell Infect Microbiol. 2022 Feb 3;11:821828. doi: 10.3389/fcimb.2021.821828. eCollection 2021.

DOI:10.3389/fcimb.2021.821828
PMID:35186784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8851474/
Abstract

The urgent approval of the use of the inactivated COVID-19 vaccine is essential to reduce the threat and burden of the epidemic on global public health, however, our current understanding of the host immune response to inactivated vaccine remains limited. Herein, we performed serum IgG antibody detection and transcriptomics analysis on 20 SARS-CoV-2 naïve individuals who received multiple doses of inactivated vaccine and 5 SARS-CoV-2 recovered individuals who received single dose of inactivated vaccine. Our research revealed the important role of many innate immune pathways after vaccination, identified a significant correlation with the third dose of booster vaccine and proteasome-related genes, and found that SARS-CoV-2 recovered individuals can produces a strong immune response to a single dose of inactivated vaccine. These results help us understand the reaction mechanism of the host's molecular immune system to the inactivated vaccine, and provide a basis for the choice of vaccination strategy.

摘要

紧急批准使用新冠灭活疫苗对于减轻全球公共卫生领域的疫情威胁和负担至关重要,然而,我们目前对于人体对灭活疫苗的免疫反应的理解仍有限。在此,我们对 20 名从未感染过 SARS-CoV-2 的个体(他们接受了多剂灭活疫苗)和 5 名曾感染过 SARS-CoV-2 的个体(他们接受了一剂灭活疫苗)进行了血清 IgG 抗体检测和转录组学分析。我们的研究揭示了接种疫苗后许多固有免疫途径的重要作用,发现与第三剂加强疫苗和蛋白酶体相关基因有显著相关性,并发现已感染 SARS-CoV-2 的个体可以对一剂灭活疫苗产生强烈的免疫反应。这些结果有助于我们了解宿主分子免疫系统对灭活疫苗的反应机制,并为疫苗接种策略的选择提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/7e9000c5c666/fcimb-11-821828-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/a6aa498cb1c5/fcimb-11-821828-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/f3c9a5fe4b66/fcimb-11-821828-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/de6e01c1d743/fcimb-11-821828-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/f3028d6abb01/fcimb-11-821828-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/f211583ad961/fcimb-11-821828-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/0b78c01e9cf5/fcimb-11-821828-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/7e9000c5c666/fcimb-11-821828-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/a6aa498cb1c5/fcimb-11-821828-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/f3c9a5fe4b66/fcimb-11-821828-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/de6e01c1d743/fcimb-11-821828-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/f3028d6abb01/fcimb-11-821828-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/f211583ad961/fcimb-11-821828-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/0b78c01e9cf5/fcimb-11-821828-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/8851474/7e9000c5c666/fcimb-11-821828-g007.jpg

相似文献

1
Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine.SARS-CoV-2 初免和康复个体接种灭活疫苗后外周血单个核细胞的转录组分析。
Front Cell Infect Microbiol. 2022 Feb 3;11:821828. doi: 10.3389/fcimb.2021.821828. eCollection 2021.
2
Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.单细胞转录组图谱揭示 COVID-19 疫苗接种和自然 SARS-CoV-2 感染之间的独特免疫反应。
J Med Virol. 2022 Nov;94(11):5304-5324. doi: 10.1002/jmv.28012. Epub 2022 Jul 30.
3
[Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?].[灭活新型冠状病毒疫苗的体液免疫反应:何时应接种加强针?]
Mikrobiyol Bul. 2022 Jul;56(3):566-573. doi: 10.5578/mb.20229715.
4
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
5
Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination.在完成一剂 SARS-CoV-2 灭活疫苗接种后,长期康复的 COVID-19 个体中出现了强大的体液和细胞免疫反应。
Front Immunol. 2022 Aug 1;13:966098. doi: 10.3389/fimmu.2022.966098. eCollection 2022.
6
Analysing transcriptomic signatures and identifying potential genes for the protective effect of inactivated COVID-19 vaccines.分析转录组特征,并鉴定灭活 COVID-19 疫苗保护作用的潜在基因。
PeerJ. 2023 Apr 19;11:e15155. doi: 10.7717/peerj.15155. eCollection 2023.
7
Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing.通过单细胞 RNA 测序描绘健康接种 BBIBP-CorV 灭活 SARS-CoV-2 疫苗者外周免疫细胞的细胞和分子变异性。
Emerg Microbes Infect. 2023 Dec;12(1):e2187245. doi: 10.1080/22221751.2023.2187245.
8
Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine.人类针对灭活的 SARS-CoV-2 疫苗的 IgM 和 IgG 反应。
Curr Med Sci. 2021 Dec;41(6):1081-1086. doi: 10.1007/s11596-021-2461-8. Epub 2021 Nov 6.
9
Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.基于 COVID-19 患者队列的 SARS-CoV-2 抗体的长期动力学和灭活疫苗对 SARS-CoV-2 抗体的影响。
Front Immunol. 2022 Jan 27;13:829665. doi: 10.3389/fimmu.2022.829665. eCollection 2022.
10
Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine.接种两剂灭活 SARS-CoV-2 疫苗的医护人员接种第三剂 mRNA-1273 疫苗后的抗体反应。
Int J Infect Dis. 2022 May;118:116-118. doi: 10.1016/j.ijid.2022.02.036. Epub 2022 Feb 19.

引用本文的文献

1
RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity.针对 COVID-19 疫苗的 RNA 编辑:揭示宿主免疫的动态表观遗传调控。
Front Immunol. 2024 Sep 6;15:1413704. doi: 10.3389/fimmu.2024.1413704. eCollection 2024.
2
Deciphering Immune Responses to Immunization via Transcriptional Analysis: A Narrative Review of the Current Evidence towards Personalized Vaccination Strategies.通过转录分析破译免疫接种的免疫反应:个性化疫苗接种策略的当前证据的叙述性综述。
Int J Mol Sci. 2024 Jun 28;25(13):7095. doi: 10.3390/ijms25137095.
3
The Initial COVID-19 Reliable Interactive DNA Methylation Markers and Biological Implications.

本文引用的文献

1
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial.一种名为 BBIBP-CorV 的新冠病毒灭活疫苗在 18 岁以下人群中的安全性和免疫原性:一项随机、双盲、对照、1/2 期临床试验。
Lancet Infect Dis. 2022 Feb;22(2):196-208. doi: 10.1016/S1473-3099(21)00462-X. Epub 2021 Sep 15.
2
Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience.两剂科兴疫苗后是否应安排第三剂加强针?一项单中心经验。
J Med Virol. 2022 Jan;94(1):287-290. doi: 10.1002/jmv.27318. Epub 2021 Sep 10.
3
Systems vaccinology of the BNT162b2 mRNA vaccine in humans.
初始新冠病毒可靠的交互式DNA甲基化标记及其生物学意义。
Biology (Basel). 2024 Apr 7;13(4):245. doi: 10.3390/biology13040245.
4
Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes.免疫应答对 SARS-CoV-2 mRNA 疫苗加强针的稳定性受 HLA 基因差异剪接的影响。
Sci Rep. 2024 Apr 18;14(1):8982. doi: 10.1038/s41598-024-59259-1.
5
Transcriptional analysis of human peripheral blood mononuclear cells stimulated by antigen.抗原刺激人外周血单个核细胞的转录分析。
Front Cell Infect Microbiol. 2023 Sep 25;13:1255905. doi: 10.3389/fcimb.2023.1255905. eCollection 2023.
6
Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation.接种流感和牛痘疫苗后免疫细胞中针对病毒的特异性和共有基因表达特征。
Front Immunol. 2023 Aug 4;14:1168784. doi: 10.3389/fimmu.2023.1168784. eCollection 2023.
7
An Update on the Application of CRISPR Technology in Clinical Practice.CRISPR 技术在临床实践中的应用进展更新。
Mol Biotechnol. 2024 Feb;66(2):179-197. doi: 10.1007/s12033-023-00724-z. Epub 2023 Jun 3.
8
Analysing transcriptomic signatures and identifying potential genes for the protective effect of inactivated COVID-19 vaccines.分析转录组特征,并鉴定灭活 COVID-19 疫苗保护作用的潜在基因。
PeerJ. 2023 Apr 19;11:e15155. doi: 10.7717/peerj.15155. eCollection 2023.
9
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients.新冠病毒奥密克戎BA.2对未感染过新冠病毒的初诊门诊患者引发的交叉变异免疫反应有限。
iScience. 2022 Nov 18;25(11):105369. doi: 10.1016/j.isci.2022.105369. Epub 2022 Oct 14.
10
Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients.与既往感染相比,奥密克戎感染的门诊患者接种疫苗可引发更强的固有免疫和体液免疫应答。
Front Immunol. 2022 Jun 15;13:916686. doi: 10.3389/fimmu.2022.916686. eCollection 2022.
人体中 BNT162b2 mRNA 疫苗的系统疫苗学。
Nature. 2021 Aug;596(7872):410-416. doi: 10.1038/s41586-021-03791-x. Epub 2021 Jul 12.
4
Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.感染与免疫记忆:SARS-CoV-2 疫苗提供强大保护的影响因素
Front Immunol. 2021 May 11;12:660019. doi: 10.3389/fimmu.2021.660019. eCollection 2021.
5
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.mRNA 疫苗接种后 SARS-CoV-2 初免者和康复者的抗体和记忆 B 细胞反应存在差异。
Sci Immunol. 2021 Apr 15;6(58). doi: 10.1126/sciimmunol.abi6950.
6
Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19.生物信息学和机器学习方法鉴定 COVID-19 中的潜在药物靶点和通路。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab120.
7
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.先前感染过 SARS-CoV-2 的个体对 BNT162b2 mRNA 疫苗的抗体反应。
Nat Med. 2021 Jun;27(6):981-984. doi: 10.1038/s41591-021-01325-6. Epub 2021 Apr 1.
8
Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.COVID-19 患者感染后三个月对 SARS-CoV-2 的持久抗体和 T 细胞应答。
Nat Commun. 2021 Feb 9;12(1):897. doi: 10.1038/s41467-021-21155-x.
9
COVID-19: Coronavirus Vaccine Development Updates.COVID-19:冠状病毒疫苗研发进展。
Front Immunol. 2020 Dec 23;11:602256. doi: 10.3389/fimmu.2020.602256. eCollection 2020.
10
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.